Life and Health Today Weekly: Fat in aging muscle may signal decline, but the science is still early
Issue of 12 October 2026
What happened last week.
- Longevity Fat in aging muscle may signal decline, but the science is still early
A review of population studies finds that fat seeping into muscle tissue accumulates steadily with age, independent of body weight or activity level, and tracks with losses in strength and mobility. Separately, a mouse study links falling levels of a membrane lipid called cardiolipin to the kind of muscle-fiber changes seen in aging humans. Neither finding is ready to change clinical practice, but both point toward measurable targets researchers are watching closely.
- Regenerative Hip osteoarthritis reshapes bone marrow immune cells, lab study finds
Researchers publishing in GeroScience found that elderly patients with hip osteoarthritis have a higher proportion of immature immune cells in their bone marrow than patients who had suffered a hip fracture. The suppressive function of those cells appeared intact in both groups. The work is early-stage laboratory science and has not yet shown whether the difference drives symptoms or could be targeted by treatment.
- Longevity Wegovy's weight-loss pill reached 100,000 new prescriptions a month in two months
The daily semaglutide tablet was taken up faster in its first months than the injections were, and injection prescriptions did not decline, according to a study in Annals of Internal Medicine. That suggests the pill may be widening treatment, not just replacing shots.
- Regenerative One child, 80 months on: gene therapy holds off a fatal brain disease
A single patient treated at 30 months of age with an experimental stem cell gene therapy for Mucopolysaccharidosis IIIA, a rare inherited disease that kills children in their late teens, showed sustained biochemical correction and better-than-expected cognitive development over nearly seven years. The findings, published in Molecular Therapy, the American Society of Gene Therapy's journal, are the longest reported follow-up for this approach and have prompted plans for a formal phase I/II clinical trial.
- Biohacking Brain immune cells, not neurons, drive alcohol damage in mice and human tissue
A Cleveland Clinic team found that microglia, the brain's resident immune cells, actively tear apart the protein scaffolding holding neurons together when exposed to heavy alcohol, rather than simply reacting to damage neurons have already suffered. The work, published in the journal Immunity, was done in mice and confirmed in post-mortem human brain tissue. A molecular switch called MyD88 appears to control the whole cascade, and blocking it in mice preserved brain structure even at high blood alcohol levels.
- Longevity Healthy habits explain only a slice of the longevity gap between rich and poor
A 20-year study of 33,541 older adults aged 65 and over across 23 provinces in China found that people with lower socioeconomic status faced a 25% higher risk of early death and a 46% higher risk of poor health in old age compared with higher-status peers. Lifestyle choices accounted for only about a fifth of that gap, suggesting other forces are doing most of the work.